| Marktkapitalisierung | 127 Mio. 114 Mio. 104 Mio. 94.79 Mio. 179 Mio. 11.88 Mrd. 184 Mio. 1.25 Mrd. 501 Mio. 6.34 Mrd. 475 Mio. 465 Mio. 20.05 Mrd. | KGV 2026 * |
-8.76x | KGV 2027 * | -7.78x |
|---|---|---|---|---|---|
| Enterprise Value (EV) | 127 Mio. 114 Mio. 104 Mio. 94.79 Mio. 179 Mio. 11.88 Mrd. 184 Mio. 1.25 Mrd. 501 Mio. 6.34 Mrd. 475 Mio. 465 Mio. 20.05 Mrd. | EV / Umsatz 2026 * |
-
| EV / Umsatz 2027 * | - |
| Streubesitz |
-
| Rendite 2026 * |
-
| Rendite 2027 * | - |
Aktuelles Transkript: Foamix Pharmaceuticals Ltd.
| % | % 5 Tage | Perf. 1 Jahr | Perf. 3 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -16.94% | - | - | 19.05 Mio. | |
| -4.83% | +2.88% | +55.87% | +69.12% | 69.4 Mrd. | |
| +0.02% | +1.42% | +12.77% | +75.21% | 57.24 Mrd. | |
| -1.34% | +3.53% | +23.22% | +101.58% | 57.62 Mrd. | |
| +2.62% | -1.17% | +29.37% | +37.84% | 43.65 Mrd. | |
| +5.09% | +9.53% | +26.62% | +121.44% | 44.03 Mrd. | |
| +8.24% | +1.06% | +224.03% | +767.69% | 38.08 Mrd. | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31 Mrd. | |
| -2.97% | -6.89% | +91.79% | +74.60% | 32.61 Mrd. | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47 Mrd. | |
| Durchschnitt | +0.28% | +2.24% | +58.51% | +145.36% | 44.93 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.05% | +2.44% | +53.94% | +138.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Umsatz | - | - |
| Nettoergebnis | -38.54 Mio. -34.6 Mio. -31.61 Mio. -28.87 Mio. -54.46 Mio. -3.62 Mrd. -56.16 Mio. -381 Mio. -153 Mio. -1.93 Mrd. -145 Mio. -142 Mio. -6.11 Mrd. | -66.89 Mio. -60.05 Mio. -54.85 Mio. -50.11 Mio. -94.51 Mio. -6.28 Mrd. -97.47 Mio. -662 Mio. -265 Mio. -3.35 Mrd. -251 Mio. -246 Mio. -10.6 Mrd. |
| Nettoverschuldung | - | - |
Beschäftigte
-
Sektor
Biotechnologie
